Composition and method of decreasing renal ischemic damage

Details for Australian Patent Application No. 2005235306 (hide)

Owner Loma Linda University

Inventors Baldwin, Dalton D.

Agent Freehills

Pub. Number AU-B-2005235306

PCT Pub. Number WO2005/102348

Priority 60/578,531 09.06.04 US; 60/563,772 19.04.04 US

Filing date 18 April 2005

Wipo publication date 3 November 2005

Acceptance publication date 21 August 2008

International Classifications

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/497 (2006.01)

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/102348 Priority application(s): WO2005/102348

21 August 2008 Application Accepted

  Published as AU-B-2005235306

18 December 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005235308-Transdermal delivery of beneficial substances effected by a hostile biophysical environment

2005235305-Apparatus and methods for securing tissue to bone